Display options
Cite
Ellert-Miklaszewska A, Ciechomska IA, Kaminska B. Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in . Cancers (Basel). 2021;13(3)doi: 10.3390/cancers13030419.
Ellert-Miklaszewska, A., Ciechomska, I. A., & Kaminska, B. (2021). Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in . Cancers, 13(3), . https://doi.org/10.3390/cancers13030419
Ellert-Miklaszewska, Aleksandra, et al. "Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in ." Cancers vol. 13,3 (2021). doi: https://doi.org/10.3390/cancers13030419
Ellert-Miklaszewska A, Ciechomska IA, Kaminska B. Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in . Cancers (Basel). 2021 Jan 22;13(3). doi: 10.3390/cancers13030419. PMID: 33499365; PMCID: PMC7865605.
Copy Download .nbib Format: NLM
Share it on

Cancers (Basel). 2021 Jan 22;13(3). doi: 10.3390/cancers13030419.

Synthetic Cannabinoids Induce Autophagy and Mitochondrial Apoptotic Pathways in Human Glioblastoma Cells Independently of Deficiency in .

Cancers

Aleksandra Ellert-Miklaszewska, Iwona Anna Ciechomska, Bozena Kaminska

Affiliations

  1. Laboratory of Molecular Neurobiology, Nencki Institute of Experimental Biology, Polish Academy of Sciences, 02-093 Warsaw, Poland.
  2. Affiliated Cancer Hospital & Institute of Guangzhou Medical University, Guangzhou 510095, China.

PMID: 33499365 PMCID: PMC7865605 DOI: 10.3390/cancers13030419

Abstract

Glioblastomas (GBMs) are aggressive brain tumors with frequent genetic alterations in

Keywords: PTEN; TP53; apoptosis; autophagy; cannabinoids; glioblastoma; mTOR; mitochondrial apoptotic pathway

References

  1. FEBS Lett. 1998 Sep 25;436(1):6-10 - PubMed
  2. J Biol Chem. 2002 Feb 15;277(7):5484-9 - PubMed
  3. Cancer Cell. 2006 Apr;9(4):301-12 - PubMed
  4. J Neuropathol Exp Neurol. 2002 Mar;61(3):215-25; discussion 226-9 - PubMed
  5. Oncogene. 2013 Mar 21;32(12):1518-29 - PubMed
  6. Glia. 2004 Dec;48(4):267-77 - PubMed
  7. Nat Rev Cancer. 2003 Oct;3(10):745-55 - PubMed
  8. Curr Opin Neurol. 2000 Dec;13(6):619-25 - PubMed
  9. J Biol Chem. 1997 May 9;272(19):12738-46 - PubMed
  10. Brain Pathol. 1999 Jul;9(3):469-79 - PubMed
  11. Curr Biol. 1998 Oct 22;8(21):1195-8 - PubMed
  12. Cell Death Differ. 2011 Jul;18(7):1099-111 - PubMed
  13. Mol Cell Biol. 2007 Dec;27(23):8284-95 - PubMed
  14. J Neurooncol. 2005 Aug;74(1):31-40 - PubMed
  15. Cancer J. 2003 Mar-Apr;9(2):82-90 - PubMed
  16. Nat Rev Cancer. 2005 Sep;5(9):726-34 - PubMed
  17. Autophagy. 2016 Nov;12(11):2213-2229 - PubMed
  18. Int J Cancer. 1996 Jun 21;69(3):236-40 - PubMed
  19. Science. 2000 Dec 1;290(5497):1717-21 - PubMed
  20. Annu Rev Pharmacol Toxicol. 2006;46:101-22 - PubMed
  21. J Neuropathol Exp Neurol. 2005 Jun;64(6):479-89 - PubMed
  22. Cancers (Basel). 2020 Apr 23;12(4): - PubMed
  23. Cell Signal. 2005 Jan;17(1):25-37 - PubMed
  24. J Neurosci. 2002 Nov 15;22(22):9742-53 - PubMed
  25. Int J Cancer. 1997 Nov 27;73(5):707-14 - PubMed
  26. J Neurosci Res. 2008 Nov 1;86(14):3212-20 - PubMed
  27. Neurochem Int. 2002 Jun;40(7):637-45 - PubMed
  28. Br J Surg. 1998 Nov;85(11):1460-7 - PubMed
  29. Science. 1992 May 8;256(5058):827-30 - PubMed
  30. Cell Death Dis. 2011 Apr 28;2:e152 - PubMed
  31. J Pharmacol Exp Ther. 2004 Mar;308(3):838-45 - PubMed
  32. Cell. 1995 May 5;81(3):323-30 - PubMed
  33. Nat Med. 2000 Mar;6(3):313-9 - PubMed
  34. Int J Cancer. 2009 Mar 1;124(5):1060-71 - PubMed
  35. Nature. 2009 Apr 30;458(7242):1127-30 - PubMed
  36. Science. 1990 Aug 24;249(4971):912-5 - PubMed
  37. J Biol Chem. 2007 Aug 17;282(33):24131-45 - PubMed
  38. Cell Death Differ. 2004 Apr;11(4):448-57 - PubMed
  39. Br J Cancer. 2006 Jul 17;95(2):197-203 - PubMed
  40. Oncogene. 2003 Oct 20;22(47):7414-30 - PubMed
  41. Ann Oncol. 1998 Jun;9(6):589-600 - PubMed
  42. Adv Exp Med Biol. 2020;1202:223-241 - PubMed
  43. J Clin Invest. 2009 May;119(5):1359-72 - PubMed
  44. J Neurochem. 2012 Mar;120(5):842-9 - PubMed
  45. Brain Res. 2007 Mar 16;1137(1):161-9 - PubMed
  46. J Neurooncol. 2006 Apr;77(2):143-52 - PubMed
  47. Cancer Res. 1994 Feb 1;54(3):649-52 - PubMed
  48. Neurochem Int. 2010 May-Jun;56(6-7):829-33 - PubMed
  49. Mol Cancer Ther. 2011 Jul;10(7):1161-72 - PubMed
  50. Clin Cancer Res. 2000 Oct;6(10):3937-43 - PubMed
  51. J Neurooncol. 2000 Sep;49(2):105-15 - PubMed
  52. Cell Mol Life Sci. 1999 Oct 30;56(5-6):481-506 - PubMed
  53. J Neurochem. 2006 Aug;98(3):886-93 - PubMed
  54. J Invest Dermatol. 2015 Jun;135(6):1629-1637 - PubMed
  55. Exp Cell Res. 2006 Jul 1;312(11):2121-31 - PubMed
  56. Brain Res. 2006 Feb 3;1071(1):10-23 - PubMed
  57. Cancer Res. 2001 Aug 1;61(15):5784-9 - PubMed
  58. Autophagy. 2008 Jan;4(1):82-4 - PubMed
  59. Biochem J. 2002 Apr 1;363(Pt 1):183-8 - PubMed
  60. Cell Death Differ. 2009 Jul;16(7):966-75 - PubMed

Publication Types

Grant support